论文部分内容阅读
近些年来,化学性胸膜粘合法已成为治疗症状性恶性胸水的常用方法,但对于良性胸水或原因不明性胸水则仍是临床上的难题。这些患者的胸水是否也可用胸膜粘合法来进行成功治疗?作者对此进行了前瞻性研究。 患者22例,男性8例,女性14例,年龄8～50岁,平均49.3岁。于1985年5月至1992年10月住院治疗。胸水原因:肝硬变6例,乳糜胸5例.系统性红斑狼疮(SLE)5例,有9例虽经胸水细胞学、胸膜活检和胸腔镜检查,未能确定病因。22例患者均符合以下选例标准:①胸水引流后肺完全膨胀,②胸腔排水后症状缓
In recent years, chemical pleural adhesion has become a commonly used method of treating symptomatic malignant pleural effusion, but it is still a clinical problem for benign pleural effusion or unexplained pleural effusion. Can pleural adhesions be used for the successful treatment of pleural effusion in these patients? The authors conducted a prospective study. 22 patients, 8 males and 14 females, aged 8 to 50 years, mean 49.3 years old. In May 1985 to October 1992 hospitalization. Causes of pleural effusion: liver cirrhosis in 6 cases, chylothorax in 5. SLE in 5 cases, 9 cases through the hydrothorax, pleural biopsy and thoracoscopy, failed to determine the cause. All 22 patients met the following selection criteria: ① pleural effusion after the lung completely inflated, ② post-drainage chest symptoms